ASPRV1 and immune system disorder: Inhibition studies on ASPRV1 may help to understand its contribution to skin barrier dysfunction [1,51], the herein described sensitivity of the enzyme to protease inhibitors reinforces the interest in studying how ASPRV1 could be potentially targeted in the treatment of immune disorders, including MS.